Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
COMPANY
ACF Equity Research
Accuracy | Clarity | Foresight
Follow
Location:
United Kingdom
57
Insights
23.9k
Views
3
Followers
Equities
Follow
Regions
Sectors
Verticals
More Filters
Refresh
Top Picks Only
Recent
bullish
•
NLS Pharmaceutics
•
14 Feb 2025 02:40
•
Issuer-paid
NLS Pharmaceutics (NLSP) Core Investment Case 13022025
NLS Pharmaceutics (NLSP:NasdaqCM) is a clinical-stage Swiss foreign issuer biotech advancing the Dual Orexin Receptor Agonist (DOXA) platform
ACF Equity Research
Follow
121 Views
Share
bullish
•
Kadimastem
•
13 Feb 2025 09:49
•
Issuer-paid
Kadimastem (KDST.TA) Core Investment Case 11022025
KDST’s T1D IsletRx program aims to revolutionize insulin production for diabetes patients using off-the-shelf allogeneic encapsulated pancreatic...
ACF Equity Research
Follow
109 Views
Share
bullish
•
Sana Biotechnology Inc
•
05 Feb 2025 22:00
•
Issuer-paid
Sana Biotechnology (SANA) Core Investment Case 05022025
Sana Biotechnology (NasdaqGS:SANA) is a well-funded cell and gene therapy innovator. Its therapies address significant unmet needs across...
ACF Equity Research
Follow
230 Views
Share
bullish
•
AsiaFIN Holdings
•
04 Dec 2024 07:47
•
Issuer-paid
AsiaFIN Holdings Corp (ASFH) - 3Q24A Beats
AsiaFIN Holdings Corp. (OTCQB : ASFH) - aggressive growth inflection point. ASFH provides IP protected fintech solutions to ASEAN based financial...
ACF Equity Research
Follow
210 Views
Share
bullish
•
BrainStorm Cell Therapeutics I
•
12 Nov 2024 22:00
•
Issuer-paid
BrainStorm Cell Therapeutics (BCLI) Update 11112024
BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI) develops NurOwn® stem cell therapy for NDDs – BCLI’s first target is ALS (MND/Lou...
ACF Equity Research
Follow
161 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.46.12
x